These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21163764)

  • 1. [Recent advances in the treatment of gastric cancer].
    Dank M
    Magy Onkol; 2010 Dec; 54(4):337-41. PubMed ID: 21163764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy for advanced gastric cancer--our possibilities in 2007].
    Dank M; Torgyík L; Szentmártoni G
    Magy Onkol; 2007; 51(3):209-17. PubMed ID: 17922060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
    Bittoni A; Maccaroni E; Scartozzi M; Berardi R; Cascinu S
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):309-14. PubMed ID: 20496540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced gastric cancer--slow but steady progress.
    Power DG; Kelsen DP; Shah MA
    Cancer Treat Rev; 2010 Aug; 36(5):384-92. PubMed ID: 20176443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Second malignancy after gastrectomy for early gastric cancer-is there any evidence that adjuvant chemotherapy for early gastric cancer causes a second malignancy ?].
    Honda I; Kobayashi D; Fukumoto R; Matsushita H; Hattori M; Nagata M; Watanabe S
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1341-5. PubMed ID: 18701845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targets in gastric and esophageal cancer.
    Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
    Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving chemotherapy for advanced gastric cancer.
    Ajani JA
    Oncologist; 2005; 10 Suppl 3():49-58. PubMed ID: 16368871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
    Kelsen D
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.
    Vogiatzi P; Vindigni C; Roviello F; Renieri A; Giordano A
    J Cell Physiol; 2007 May; 211(2):287-95. PubMed ID: 17238139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Anticancer Res; 2007; 27(5B):3535-9. PubMed ID: 17972514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
    Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
    Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
    Wagner AD; Moehler M
    Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer.
    Catalano V; Labianca R; Beretta GD; Gatta G; de Braud F; Van Cutsem E
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):127-64. PubMed ID: 19230702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stomach cancer].
    Bouché O; Lagarde S
    Rev Prat; 2005 Jan; 55(2):123-30. PubMed ID: 15825991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
    Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.
    Zhang D; Fan D
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1369-78. PubMed ID: 17944563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present status and prospects for chemotherapy for advanced or recurrent gastric cancer in our hospital].
    Yamamoto M; Matsuyama A; Emi Y; Yano S; Kameyama T; Okamoto M; Kuma S; Utsunomiya T; Ishida T
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):441-4. PubMed ID: 18347393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer].
    Yano S; Ninomiya M; Sasaki H; Umeoka T; Harano M; Aoki H; Onoda T; Shiozaki S; Ohno S; Higaki K; Takakura N
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1720-2. PubMed ID: 15553694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.